Biological heterogeneity and length-biased sampling in asymptomatic neurosurgical patients

British Journal of Neurosurgery

Volumn 22, Issue 3, 2008, Pages 368-372

  Yoshimoto, Y ^a   Tanaka, Y ^b  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Heterogeneity; Length bias; Natural history

Indexed keywords

ARTICLE; BIOLOGICAL ACTIVITY; BRAIN DAMAGE; CELL HETEROGENEITY; DIAGNOSTIC PROCEDURE; DISEASE MODEL; FREQUENCY ANALYSIS; HUMAN; IMAGING; LENGTH BIASED SAMPLING; NEUROSURGERY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT PLANNING;

BIAS (EPIDEMIOLOGY); BRAIN NEOPLASMS; HUMANS; INCIDENTAL FINDINGS; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 45849113288     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690801942916     Document Type: Article

References (18)

1. Gates TJ. Screening for cancer: evaluating the evidence. Am Fam Physician 2001;63:513-22.
2. Kafadar K, Prorok PC. Computational methods in medical decision making: to screen or not to screen? Statist Med 2005;24:569-81.
3. Pelikan S, Moskowitz M. Effects of lead time, length bias, and false-negative assurance on screening of breast cancer. Cancer 1993;71:1998-2005.
4. Schilling FH, Spix C, Berthold F, et al. Neuroblastoma screening at one year of age. N Engl J Med 2002;346:1047-53.
5. Woods WG, Gao R, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002;346:1041-6.
6. Nishi M, Miyake H, Takeda T, et al. Effects of the mass screening for neuroblastoma in Sapporo City. Cancer 1987;60:433-6.
7. Sawada T, Hirayama M, Nakata T, et al. Mass screening for neuroblastoma in infants in Japan: interim report of a mass screening study group. Lancet 1984;4:271-3.
8. Nishihara H, Toyada Y, Tanaka Y, et al. Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J Clin Oncol 2000;18:3012-7.
9. Yamamoto K, Hayashi Y, Hanada R, et al. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan. J Clin Oncol 1995;13:2033-8.
10. Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G. Natural history of conservatively treated meningiomas. Neurology 2004;63:1133-4.
11. Yoshimoto Y. Systematic review of the natural history of vestibular schwannoma. J Neurosurg 2005;103:59-63.
12. The International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725-33.
13. The International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103-10.
14. Morita A, Fujiwara S, Hashi K, Ohtsu H, Kirino T. Risk of rupture associated with intact cerebral aneurysms in the Japanese population: a systematic review of the literature from Japan. J Neurosurg 2005;102:601-6.
15. Rinkel GJE, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms. A systematic review. Stroke 1998;29:251-6.
16. Kataoka K, Taneda M, Asai T, Yamada Y. Difference in nature of ruptured and unruptured cerebral aneurysms. Lancet 2000;355:203.
17. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
18. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.